OTC Markets OTCQB - Delayed Quote USD

Odyssey Health, Inc. (ODYY)

Compare
0.0280 0.0000 (0.00%)
As of October 21 at 10:00 AM EDT. Market Open.
Loading Chart for ODYY
DELL
  • Previous Close 0.0280
  • Open 0.0280
  • Bid 0.0185 x --
  • Ask 0.0275 x --
  • Day's Range 0.0280 - 0.0280
  • 52 Week Range 0.0180 - 0.1580
  • Volume 3,000
  • Avg. Volume 24,643
  • Market Cap (intraday) 2.698M
  • Beta (5Y Monthly) -0.67
  • PE Ratio (TTM) 0.28
  • EPS (TTM) 0.1000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.

www.odysseyhealthinc.com

6

Full Time Employees

July 31

Fiscal Year Ends

Recent News: ODYY

View More

Performance Overview: ODYY

Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ODYY
72.00%
S&P 500
22.47%

1-Year Return

ODYY
71.43%
S&P 500
38.29%

3-Year Return

ODYY
90.94%
S&P 500
28.39%

5-Year Return

ODYY
87.27%
S&P 500
52.74%

Compare To: ODYY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ODYY

View More

Valuation Measures

Annual
As of 10/21/2024
  • Market Cap

    2.70M

  • Enterprise Value

    4.23M

  • Trailing P/E

    0.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.34

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    0.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -27.05%

  • Return on Equity (ttm)

    1,076.39%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    11.02M

  • Diluted EPS (ttm)

    0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    66.01k

  • Total Debt/Equity (mrq)

    20.31%

  • Levered Free Cash Flow (ttm)

    -373.89k

Research Analysis: ODYY

View More

Company Insights: ODYY

Research Reports: ODYY

View More

People Also Watch